Suppr超能文献

甲状腺切除术后的症状性低钙血症:通过预防性治疗和风险适应性替代相结合的方法进行预防

[Symptomatic hypocalcemia after thyroidectomy : Prevention by a combination of prophylaxis and risk-adapted substitution].

作者信息

Coerper S, Dehnel J, Stengl W

机构信息

Klinik für Allgemein- und Visceralchirurgie, Referenzzentrum für Schilddrüsen- und Nebenschilddrüsenchirurgie, Krankenhaus Martha-Maria, Stadenstraße 58, 90491, Nürnberg, Deutschland.

出版信息

Chirurg. 2018 Nov;89(11):909-916. doi: 10.1007/s00104-018-0631-4.

Abstract

BACKGROUND

Treatment of hypocalcemia after thyroidectomy consists of an individual substitution, prophylaxis or a daily administration of calcium/vitamin D3.

OBJECTIVE

Does prophylactic therapy combined with a risk-adapted substitution of calcium and vitamin D3 reduce symptomatic hypocalcemia compared to individual substitution?

MATERIAL AND METHODS

After implementation of a new algorithm, patient data were prospectively documented and analyzed compared to a historical patient population. The algorithm consisted of a single prophylactic i. v. administration of calcium (1 g calcium gluconate 10% in 250 ml saline) and a risk-adapted oral administration of calcium and vitamin D3 after surgery. Patients without risk (parathyroid hormone, PTH > 15 pg/ml) were not treated. Patients with a low risk (PTH ≥ 6 ≤ 15 pg/ml and Ca > 2.0 mmol/l) received 3 g calcium, patients with a high risk (PTH ≥ 6 ≤ 15 pg/ml and Ca < 2.0 mmol/l) received 3 g calcium and 2 × 0.5 µg vitamin D3 and patients with a very high risk (PTH < 6 pg/ml) got 4 g calcium and 2 × 0.5 µg vitamin D3.

RESULTS

In this study 415 patients were included (230 prospectively and 185 retrospectively). Serum calcium of patients with individual substitution increased significantly at day 1 (p = 0.0001) and the number of patients with critical hypocalcemia (Ca < 2.0 mmol/l) decreased by half (27% vs. 12.2%; p = 0.0001). There was a significantly lower rate of symptomatic patients (24.9% vs 13.0%; p = 0.002) and a clear reduction of patients with a prolonged hospitalization (10.8% vs. 6.5%; p = 0.08). The rate of permanent hypocalcemia was comparable (2.2% vs. 2.1%). In the risk groups there was a significantly different rate of hypocalcemia: patients without risk (n = 170) in 2.2%, patients with low risk (n = 36) in 25%, patients with high risk (n = 13) in 69.2% and patients with very high risk (n = 11) in 71%.

CONCLUSION

This new treatment regimen is practicable, significantly lowers the symptoms, also in comparison to the literature and shows a clear differentiation between the risk groups.

摘要

背景

甲状腺切除术后低钙血症的治疗包括个体化替代治疗、预防性治疗或每日补充钙/维生素D3。

目的

与个体化替代治疗相比,预防性治疗联合根据风险调整的钙和维生素D3替代治疗是否能降低症状性低钙血症的发生率?

材料与方法

在实施一种新算法后,与历史患者群体相比,对患者数据进行前瞻性记录和分析。该算法包括单次预防性静脉注射钙(1g 10%葡萄糖酸钙加入250ml生理盐水中)以及术后根据风险调整的钙和维生素D3口服给药。无风险患者(甲状旁腺激素,PTH>15pg/ml)不进行治疗。低风险患者(PTH≥6≤15pg/ml且Ca>2.0mmol/l)给予3g钙,高风险患者(PTH≥6≤15pg/ml且Ca<2.0mmol/l)给予3g钙和2×0.5μg维生素D3,极高风险患者(PTH<6pg/ml)给予4g钙和2×0.5μg维生素D3。

结果

本研究纳入415例患者(前瞻性纳入230例,回顾性纳入185例)。个体化替代治疗患者的血清钙在第1天显著升高(p = 0.0001),严重低钙血症(Ca<2.0mmol/l)患者数量减少一半(27%对12.2%;p = 0.0001)。有症状患者的比例显著降低(24.9%对13.0%;p = 0.002),住院时间延长的患者明显减少(10.8%对6.5%;p = 0.08)。永久性低钙血症的发生率相当(2.2%对2.1%)。在各风险组中,低钙血症的发生率有显著差异:无风险患者(n = 170)为2.2%,低风险患者(n = 36)为25%,高风险患者(n = 13)为69.2%,极高风险患者(n = 11)为71%。

结论

这种新的治疗方案切实可行,与文献报道相比,能显著减轻症状,且在风险组之间有明显区分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验